AC Immune (ACIU) Cash from Operations (2016 - 2025)
AC Immune has reported Cash from Operations over the past 10 years, most recently at 20932070.62 for Q4 2025.
- Quarterly Cash from Operations fell 409.02% to 20932070.62 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 85385299.71 through Dec 2025, down 217.97% year-over-year, with the annual reading at 88795520.12 for FY2025, 218.14% down from the prior year.
- Cash from Operations was 20932070.62 for Q4 2025 at AC Immune, up from 23352045.73 in the prior quarter.
- Over five years, Cash from Operations peaked at 80752780.98 in Q2 2024 and troughed at 25059434.29 in Q1 2022.
- The 5-year median for Cash from Operations is 17904454.47 (2022), against an average of 11448316.5.
- Year-over-year, Cash from Operations skyrocketed 611.76% in 2024 and then crashed 1935.27% in 2025.
- A 5-year view of Cash from Operations shows it stood at 18821533.9 in 2021, then increased by 6.25% to 17644296.46 in 2022, then fell by 4.59% to 18454792.73 in 2023, then soared by 136.7% to 6773790.65 in 2024, then crashed by 409.02% to 20932070.62 in 2025.
- Per Business Quant, the three most recent readings for ACIU's Cash from Operations are 20932070.62 (Q4 2025), 23352045.73 (Q3 2025), and 19570237.49 (Q2 2025).